We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
LightCOM
Study
lightbar@phc.ox.ac.uk
Olivia
Adams
lightbar@phc.ox.ac.uk
Prof
Susan
Jebb
Susan.jebb@phc.ox.ac.uk
Kathryn
Hubbard
kathryn.hubbard@phc.ox.ac.uk
Sarah
Wane
sarah.wane@phc.ox.ac.uk
Daisy
Harrison
lightbar@phc.ox.ac.uk
Obesity and other hyperalimentation
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
What is the study about?
We are looking at different treatments for people who are living with obesity to see what can improve health and quality of life. For people who haven’t been able to lose weight any other way, an option is weight loss surgery but we have some evidence that a combination of other treatments may be just as helpful. The treatment we want to test is a two year programme which includes weight loss coaching and dieting.
Who can take part?
We are running this study in partnership with hospitals around the UK and in order to take part you must have been invited by one of these hospitals directly. You won't be able to access the study unless you have been invited. If you are under the care of one of these hospitals and you are eligible to take part, you will receive contact from them.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Interventional type: Drug;Psychological & Behavioural;Surgery;
You can take part if:
You may not be able to take part if:
Prior bariatric or hiatal surgery, not including intragastric balloons or duodenal-jejunal bypass sleeve (Endobarrier™ or similar) if the device has been removed > 1 year before screening. Use of any WLM (including liraglutide and semaglutide for diabetes) within last 3 months. Conditions that contraindicate or complicate total diet replacement (including diabetes requiring basal bolus insulin therapy or insulin pump therapy, phenylketonuria, or other conditions requiring strict adherence to special diets). Conditions that contraindicate or complicate treatment with GLP-1 receptor analogues (including history of pancreatitis or known allergies). Conditions that contraindicate or complicate bariatric surgery (GI motility disorders, large abdominal wall hernia, large hiatus hernia (> 5cm), Crohn’s disease, liver cirrhosis, or other conditions preventing laparoscopic bariatric surgery e.g. multiple previous abdominal surgery). Conditions that contraindicate or complicate study adherence and bariatric surgery (mental disorder, unstable psychiatric disease, recent history of alcohol/medication abuse). Pregnant or planning pregnancy in the next two years or currently breast feeding. Not achieving a 5% weight loss within 12 weeks prior to randomisation. Another member of the household enrolled in the trial.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Kathryn
Hubbard
kathryn.hubbard@phc.ox.ac.uk
Sarah
Wane
sarah.wane@phc.ox.ac.uk
LightCOM
Study
lightbar@phc.ox.ac.uk
Prof
Susan
Jebb
Susan.jebb@phc.ox.ac.uk
Olivia
Adams
lightbar@phc.ox.ac.uk
Daisy
Harrison
lightbar@phc.ox.ac.uk
The study is sponsored by Copenhagen University Hospital and funded by NOVO NORDISK FONDEN (Denmark) .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 58098
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
